Eric Adler

Insider Reports History

Entity
Individual
Location
C/O Lexeo Therapeutics, Inc., 345 Park Avenue South, 6 Th Floor, New York, NY
Signature
/s/ Youjin Choi, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric Adler:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lexeo Therapeutics, Inc. Chief Medical Officer Common Stock 68.3K $301K $4.41 Feb 19, 2025 Direct
Lexeo Therapeutics, Inc. Chief Medical Officer Stock Option (right to buy) 87.5K Jan 7, 2025 Direct

Insider Reports Filed by Eric Adler

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LXEO Lexeo Therapeutics, Inc. Feb 19, 2025 1 -$10.4K 4 Feb 21, 2025 Chief Medical Officer
LXEO Lexeo Therapeutics, Inc. Jan 7, 2025 2 $0 4 Jan 10, 2025 Chief Medical Officer
LXEO Lexeo Therapeutics, Inc. Feb 2, 2024 2 $0 4 Feb 6, 2024 Chief Medical Officer
LXEO Lexeo Therapeutics, Inc. Nov 2, 2023 0 $0 3 Nov 2, 2023 Chief Scientific Officer